The study of primary and acquired resistance to first-line osimertinib to improve the outcome of EGFR-mutated advanced Non-small cell lung cancer patients: the challenge is open for new therapeutic strategies

Giulia Pasello Giulia Pasello (MD, PhD) is Associate Professor in Oncology at the Department of Surgery, Oncology and Gastroenterology, University of Padova, and Medical Oncologist at the Istituto Oncologico Veneto IRCCS in Padova (Italy). She received Residency in Oncology in 2010 with full marks with a translational thesis work on Malignant Pleural Mesothelioma (MPM) “Induction of senescence markers after neo-adjuvant chemotherapy of malignant pleural mesothelioma and association with clinical outcome: an exploratory analysis”. This work was conducted at the molecular oncology laboratories of the University of Zurich where she spent the last 6 months of residency school. Dr. Pasello received a PhD in Experimental, Medical and Clinical Sciences of the University of Padova in 2014, with a research project on neoangiogenic biomarkers and therapeutic targets in malignant pleural mesothelioma. In 2019, Since 2010 she has coordinated several translational projects on MPM and lung cancer, which are the main topic of her clinical and translational research activity, with particular reference to new treatment targets discovery, innovative drugs development, and assesment/monitoring of inflammatory tissue and circulating predictive and prognostic biomarkers. Dr. Pasello is extensively published in peer-review journals with more than 100 papers and some books chapter and has delivered several talks in Italian and International conferences. She additionally has been a member of the scientific committee of national and international conferences on thoracic oncology. Currently, she is associate editor of Frontiers in Oncology and Pulmonology. She is currently assistant professor in Oncology at the Department of Surgery, Oncology and Gastroenterology of University of Padova Dr. Pasello has been recipient of national and international research grants for translational studies on thoracic cancers.

留言 (0)

沒有登入
gif